Company BioDelivery Sciences International, Inc.
Equities
BDSI
US09060J1060
Pharmaceuticals
Business Summary
Number of employees: 200
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Ciaffoni
CEO | Chief Executive Officer | 53 | 22/22/22 |
Colleen Tupper
DFI | Director of Finance/CFO | 48 | 22/22/22 |
Shirley Kuhlmann
LAW | General Counsel | 40 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 443 | 0 | 0 | 91.41 % |
Stock B | 1 | 106,494,480 | 97,342,470 ( 91.41 %) | 3,265,684 ( 3.067 %) |
Company contact information
BioDelivery Sciences International, Inc.
100 Technology Center Drive Suite 300
02072, Stoughton
+919 582 9050
http://www.bdsi.comSector
1st Jan change | Capi. | |
---|---|---|
+32.36% | 695B | |
+26.51% | 568B | |
-4.40% | 361B | |
+19.46% | 330B | |
+3.50% | 283B | |
+16.92% | 239B | |
+8.24% | 204B | |
-7.53% | 198B | |
+8.62% | 168B |